May 5, Saturday

8 A.M.-NOON

COURSES 1-2

SEMINAR

SM1. Sexual Compulsivity and AddictionsChair: Ken Rosenberg, M.D.

8 A.M.-5 P.M.

COURSE 3

9 A.M.-4 P.M.

COURSES 4-7

MASTER COURSES

MC01. 2012 Psychiatry ReviewThe American College of Psychiatrists; Chairs: Arden D. Dingle, M.D., Robert J. Boland, M.D.

MC02. Challenges in Psychodynamic PsychotherapyChair: Glen O. Gabbard, M.D.

SEMINAR

SM2. The International Medical Graduate InstituteChair: Nyapati R. Rao, M.D., M.S.

9 A.M.-10:30 A.M.

SCIENTIFIC AND CLINICAL REPORT

SCR1. AIDS/HIV

1. Contributory Effects of Childhood Trauma to White Matter Tract Injury in Human Immunodeficiency Virus (HIV) Infected and Uninfected Women S oraya Seedat, M.D., Ph.D.

2. Mental Health Outcomes for Orphans by AIDS Compared to Orphans by Other Means Carla Sharp, Ph.D.

3. The Outpatient Clinic for HIV and Mental Health: Patients’ Characteristics and Comparison With Homosexual Non-HIV Infected Patients Annemiek Schadé, M.D., Ph.D.

FORUM

F1.DSM-5:Research and DevelopmentChair: David J. Kupfer, M.D.

LECTURE

L1. Deep Brain Stimulation: Rethinking Depression and Its TreatmentAPA Frontiers of Science Lecture; Helen S. Mayberg, M.D.

9 A.M.-NOON SYMPOSIA

S1. One-Stop Psychiatric Shopping: How to Integrate Medication and Psychotherapy in Your Practice

1. Integrative Strategies in Treating Eating Disorders Joel Yager, M.D.

2. Exploring the Meaning of Medications David L. Mintz, M.D.

3. Combining CBT and Pharmaco-therapy in Brief Sessions Jesse H. Wright, M.D., Ph.D.

4. A Private Psychiatric Practice in Rural Vermont: A Return to the Old Frontier Alice Silverman, M.D.

S2. Scope, Current Evidence, and Innovative Approaches in Managing PTSD in the Military

1. Epidemiology and Treatment of PTSD Associated With Combat: A Critical Look at the Evidence Gary H. Wynn, M.D.

2. Psychopharmacologic Treatment for PTSD David M. Benedek, M.D.

3. Understanding the Evidence on Evidence-Based Psychotherapy for PTSD Paula P. Schnurr, Ph.D.

4. Disseminating Effective, Integrated Mental Health and Primary Care Services for PTSD and Depression in the U.S. Military Charles C. Engel, M.D., M.P.H.

5. DoD/APIRE PTSD Care Dissemination Project Farifteh F. Duffy, Ph.D.

S3. Cross-Cultural Issues in the Use of Psychotropic Medications in ChildrenAPA Council on Children, Adolescents, and Their Families 1. Perspectives on the Use of Psych-otropic Medications in Children in the United States David A. Mrazek, M.D.

2. Perspectives on the Use of Psych-otropic Medications in Children in the United Kingdom Sue Bailey, M.D.

3. Perspectives on the Use of Psycho-tropic Medications in Children in Canada Alice A. Charach, M.D.

4. Perspectives on the Use of Psych-otropic Medications in Children in New Zealand P.G. Shelton, M.D.

S4. A Primer on Prevention in Psychiatry

1. An Introduction to Prevention Principles Ruth S. Shim, M.D., M.P.H.

2. Considering Schizophrenia From a Prevention Perspective Michael T. Compton, M.D., M.P.H.

3. Suicide Prevention Frederick J.P. Langheim, M.D., Ph.D.

4. Substance Abuse Prevention Rebecca A. Powers, M.D.

5. A Primer on Prevention in Psychiatry Christopher J. Oleskey, M.D., M.P.H.

S5. Personality Disorders:DSM-5and Beyond

1. Framing the Debate for DSM-5 Personality Disorders Steven Huprich, Ph.D.

2. Proposed Revisions for DSM-5 Personality Disorders: A Process-Focused Critique and Suggestions for Future Work Groups Robert F. Born-stein, Ph.D.

3. Is There Sufficient Empirical Support for the Proposed Changes for DSM-5 in Diagnosing Personality Disorders? Mark Zimmerman, M.D.

4. Does Neurobiology Support Dimensional Diagnosis of Personality Disorders? Joel Paris, M.D.

5. DSM-5 Personality Disorders and Beyond John Livesley, M.D.

S6. The Long-Term Course of Borderline Personality Disorder: 16-Year Findings From the McLean Study of Adult Development

1. Attainment and Stability of Symptomatic Remission and Recovery Among Patients With BPD and Axis II Comparison Subjects: A 16-Year Follow-Up Study Mary C. Zanarini, Ed.D.

2. Predictors of Suicide Attempts in Patients With BPD Over 16 Years of Prospective Follow-Up Michelle M. Wedig, Ph.D.

3. Utilization of Inpatient and Out-patient Medical Services by Patients With BPD and Axis II Comparison Subjects Over a Decade of Prospective Follow-Up Alex S. Keuroghlian, M.D., M.Sc.

4. Subtypes of Identity Disturbance and Their Impact on the Course of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up Valerie I. Photos, Ph.D.

5. Opioid Use Among Patients With BPD Followed Prospectively for a Decade: Description and Prediction Frances R. Frankenburg, M.D.

S7. Spectrum Disorders: The Syndromal Overlap of Anxiety, Affective Symptoms, and Medical Comorbidity

1. Joint Hypermobility and Anxiety: The Connective Issue Antonio Bulbena, M.D., M.Sc.

2. The ALPIM Syndrome: Anxiety of the Mind and Body, Part I Singh Deepan, M.B.B.S

3. Beyond the Serotonin Hypothesis: Mitochondria and Inflammation in Major Depression and Affective Spectrum Disorders Ann Gardner, M.D., Ph.D.

S8. Integrating the Full Spectrum of Alcohol and Other Drug Problems in Psychiatric and Primary Care

1. Treating Patients With First-Episode Psychosis and Alcohol and Other Drug Use Disorders Robert E. Drake, M.D.

2. The Importance of Integrating Alcohol Treatment Within Mental Health Care Constance M. Weisner, D.P.H., M.S.W.

3. Screening and Treatment of Alcohol Use Among Depression Patients Derek D. Satre, Ph.D.

4. Pharmacotherapy of Alcohol Dependence in Serious and Persistent Mental Illness Steven L. Batki, M.D.

S9. Financing Sustainable Interdisciplinary Care in Psychiatric and General Medical Settings

1. Clinical and Systems-Level Models for Improving Care on the Primary Care/Mental Health Interface Benjamin G. Druss, M.D., M.P.H.

2. The High Cost of Comorbid Chronic Medical and Behavioral Conditions: An Opportunity for Creative Payment Reform for Integrated Medical-Behavioral Care Stephen P. Melek

3. Carved In, Carved Out, and Cut Up: The Status Quo of Current Funding Schemes for Integrated Psychiatric Treatment and Primary Care Anita S. Everett, M.D.

4. Integrated Claims Adjudication as a Strategy for Reversing the Negative Effects of Comorbid General Medical and Psychiatric Disorders Roger Kathol, M.D.

9 A.M.-NOON

MEDIA WORKSHOP

MW1. “The Celluloid Closet”: A Documentary About the Development of Gay Movie Characters and Its Relation to the Coming-Out ProcessChairs: Eric Yarbrough, M.D., Christopher A. McIntosh, M.D., M.Sc.

9 A.M.-10:30 A.M.

WORKSHOPS

W1. Update on Parasomnias: A Review for Psychiatric PracticeChairs: Dimitri D. Markov, M.D., Marina Goldman, M.D.

W2. Management Strategies for Antisocial Personality DisordersChair: Donald W. Black, M.D.

W3. Reefer Madness? The Role of Psychiatry in the Evolution of Marijuana as a Medical TreatmentChair: Christopher A. Milburn, M.D., M.S.

W4. Prevention of Mental Health Sequelae: Evidence-Based Practices in Protection, Prevention, and Intervention in African-American PopulationAPA Caucus of Black Psychiatrists; Chairs: Napoleon B. Higgins, M.D.

W5. Workshop on Integration of Primary Care, Preventive Services, and Assertive Community Treatment TeamChairs: Erik R. Vanderlip, M.D., Nancy A. Williams, M.D.

W6. A Historical Overview of the Inception of Moral Treatment in PsychiatryChair: David S. Roby, M.D.

W7. Training for the Future: Addressing Community Psychiatry Workforce Shortages and Health Care Reform Through Resident Training in Public PsychiatryChairs: Matthew D. Erlich, M.D., Sharat G. Parameswaran, M.D.

10 A.M.-11:30 A.M.

Resident Competition Poster Session 1

11 A.M.-12:30 P.M.

FORUM

F2. Alcohol Screening and Brief Intervention for Youth:The NIAAA Practitioner’s GuideChair: Vivian B. Faden, Ph.D.

LECTURE

L2. Judd Marmor Award LectureRobert E. Hales, M.D.

SCIENTIFIC AND CLINICAL REPORT

SCR2. Attention Spectrum Disorders 2

1. Prevalence of ADHD and Comorbid Psychiatric Disorders in a Veterans Administration Outpatient Clinic Robert Kayser, M.D.

2. Adult Attention-Deficit/Hyperactivity Disorder and Anxiety Disorders: Prevalence in a Clinical Sample Michael Van Ameringen, M.D.

3. Duration of Action of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyper-activity Disorder David Coghill, M.D.

WORKSHOPS

W8. Helping Patients Who Drink Too Much: Using theNIAAA Clinician’s GuideU.S. National Institute on Alcohol Abuse and Alcoholism; Chair: Mark L. Willenbring, M.D.

W9. The Ethics of Patient-Targeted GooglingChair: David H. Brendel, M.D., Ph.D.

W10. Health Care Reform and Psychiatry Training for Primary Care Physicians: What to Teach, How to Teach, Where to TeachChairs: Hoyle Leigh, M.D., Jon Streltzer, M.D.

W11. Electronic Health Records (EHRs): What to Look for When Selecting an EHR for Your PracticeAPA Committee on Electronic Health Records; Chairs: Steven R. Daviss, M.D., Robert M. Plovnick, M.D., M.S.

W12. Addressing Addiction Among Women: A U.S.A. PerspectiveChair: Pedro Ruiz, M.D.

W13. Evidence-Based Integrative Treatments for Anxiety, Depression, and Trauma in Mass DisastersAPA Caucus on Alternative and Complimentary Medicine; Chairs: Helen Lavretsky, M.D., M.S., Patricia L. Gerbarg, M.D.

1 P.M.-5 P.M.

COURSES 8-9

SEMINAR

SM3. Evidence-Based Psychodynamic Therapy: A Clinician’s GuideChairs: Richard F. Summers, M.D., Jacques P. Barber, Ph.D.

1:30 P.M.-3 P.M.

LECTURES

L3. Understanding Patients With Borderline Personality DisorderAPA International Psychiatrist Lecture; Sabine C. Herpertz, M.D.

L4. Dialectical Behavior Therapy: Where It Started, Where It Went, Where It May Be Now, and Where Are We Going?APA Frontiers of Science Lecture; Marsha M. Linehan, Ph.D.

L5. Teaching Illness Self-Management to Improve the Integration of Care Among HispanicsSimon Bolivar Award Lecture; Alex J. Kopelowicz, M.D.

WORKSHOPS

W14. Psychiatrists’ Response to Young Adult Patients Who Have Had Inappropriate or Abusive Care in Residential Treatment as AdolescentsChair: Charles W. Huffine, M.D.

W15. Computer-Assisted Cognitive-Behavior Therapy for DepressionChairs: Jesse H. Wright, M.D., Ph.D., Michael E. Thase, M.D.

W16. 2012 Revision of the Schizophrenia Psychopharmacology Algorithm From the Harvard South Shore Psychiatry ProgramChair: David N. Osser, M.D.

W17. Promoting Emotional and Physical Safety During Residency: Being Prepared for Life-Threatening Emergencies Chairs: Curtis A. McKnight, M.D., David P. Kasick, M.D.

W18. Clinical Wisdom in Psychotherapy: A Philosophical and Qualitative ReportAPA/The Scattergood Foundation; Chair: Dominic Sisti, Ph.D.

W19. Don’t You Want to Be a Real Doctor? Overcoming Career Development Challenges Faced by Asian Americans in PsychiatryAPA Caucus of Asian-American Psychiatrists; Chairs: Sharat G. Parameswaran, M.D., Russell F. Lim, M.D.

1:30 P.M.-3 P.M.

SCIENTIFIC AND CLINICAL REPORTS

SCR3. Biological Studies of Brain Functioning

1. Brain-Derived Neurotrophic Factor Moderates Effects of Job Stress on the Severity of Alcohol Drinking in Korean 20s Office Workers BoAh Kim, M.D.

2. Significant Association Between IQ and Degree of Overall Cortical Gyrification Venkataramana Bhat, M.D.

SCR4. Bipolar Disorders, Part 1

1. The Clinical Demographics of the Mayo Clinic Bipolar Disorder Biobank Manuel Fuentes, M.D.

2. Diagnostic Stability of DSM-IV Clinical Diagnosis of Bipolar Disorder Bonnie Szarek, R.N.

3. Should the Diagnostic Criteria for Bipolar Disorder be Broadened? Implications From Longitudinal Studies of Sub-threshold Conditions Mark Zimmerman, M.D.

4. Misuse of the Mood Disorders Questionnaire as a Case-Finding Measure and a Critique of the Concept of Using a Screening Scale for Bipolar Disorder Mark Zimmerman, M.D.

2 P.M.-3:30 P.M.

RESIDENT COMPETITION POSTER SESSION 2

MEDIA WORKSHOP

MW2. Lucy Ozarin, M.D.: An Inspiring Life of One Who Continues on Her Path of Learning and GivingChair: Leah J. Dickstein, M.D., M.A.

2 P.M.-5 P.M.

PRESIDENTIAL SYMPOSIA

PS1. Teaching Psychodynamic Psychiatry in the 21st CenturyChairs: John Oldham, M.D., Carol Nadelson, M.D.

1. Teaching Psychotherapy Deborah Cabaniss, M.D.

2. Everyone Is a Psychoanalyst Richard F. Summers, M.D.

3. Making It So: Creating a Psycho-dynamic Research Clinic Kimberlyn Leary, Ph.D., M.P.A.

PS2. Mindfulness-Based Practices in the Treatment of Stress and Psychiatric IllnessChair: Kathy M. Sanders, M.D.

1. Mindfulness-Based Stress Reduction (MBSR): What It Is and Its Clinical Applications for Stress, Pain, and Chronic Illness Jon Kabat-Zinn, Ph.D.

2. Mindfulness-Based Cognitive Therapy (MBCT) in the Treatment and Prevention of Relapse in Major Recurrent Depression Peter Beiling, Ph.D.

3. Probing the Molecular Mechanism of Mind-Body Practices With Genomic and Translational Techniques John W. Denninger, M.D., Ph.D.

4. Changes in Neural Structure and Function Associated With Mindfulness Training Programs Sara Lazar, Ph.D.

SYMPOSIA

S10. Social Stress and Drug Addiction in Preclinical and Clinical Studies: Sex/Gender Matters in Effects on Brain and Behavior and Treatment Implications

1. Monkey Models of Social Stress and Cocaine Abuse: Sex Differences Michael A. Nader, Ph.D.

2. Social Stress Differentially Affects Drug Reward in Adolescent Male and Female Rats Sari Izenwasser, Ph.D.

3. From Picture to Practice: The Role of Gender and Affect on the Neural Response to Social Stress in Cocaine Users Colleen A. Hanlon, Ph.D.

4. Sex Difference in Reactivity to Laboratory-Induced Stress and Drug Cues Sudie Back, Ph.D.

S11. Field Trial Testing of Proposed Revisions toDSM-5:Findings and ImplicationsAmerican Psychiatric Institute for Research and Education

1. DSM-5 Field Trials: New Methods, New Insights Helena C. Kraemer, Ph.D.

2. DSM-5 Field Trials in Academic or Large Clinical Settings: Detailed Findings for Schizophrenia, Depression, and ADHD Darrel A. Regier, M.D., M.P.H.

3. DSM-5 Field Trials in Academic or Large Clinical Settings: Summary and Implications Diana E. Clarke, Ph.D., M.Sc.

4. Dimensional Measures in Psychiatric Diagnosis: Results From the DSM-5 Field Trials William E. Narrow, M.D., M.P.H.

5. Testing DSM-5 in Routine Clinical Practice Settings: Trials, Tribulations, and Triumphs Eve K. Moscicki, Sc.D., M.P.H.

S12. Rebound and Recovery in the AthleteInternational Society for Sport Psychiatry

1. Doping in Sports: What‘s on the Horizon? David A. Baron, D.O.

2. Sexual Harassment and Abuse in Sports: What It Is, How to Prevent It. Discussion With Former NHL Player Sheldon Kennedy Saul I. Marks, M.D.

3. Psychological Impact of Injury on the Athlete Thomas S. Newmark, M.D.

4. Doping in Elite Cycling: A Psychiatric Perspective on Causes, Consequences, Recovery, and Rehabilitation Alan Currie, M.B.B.S.

S13. Time-Limited Psychotherapy for Cancer: From Diagnosis to Remission or End of Life

1. Assessment and Treatment of Cancer Patients for Time-Limited Psychotherapy: Who’s Appropriate at What Stage? Anton C. Trinidad, M.D.

2. Palliative Psychotherapy—When the Prognosis Seems Bleak Lorenzo Norris, M.D.

3. Case Presentation I Amanda Crosier, M.D.

4. Case Presentation II Sanaz Kumar, M.D.

S14. When Your Patient Is a Parent: Supporting the Family and Addressing the Needs of Children

1. Overview of Needs of the Children of Parents With Mental Illness Alison M. Heru, M.D.

2. Clinical Implications of Evidence-Based Preventive Interventions for Families With Parental Depression William R. Beardslee, M.D.

3. A Family Perspective from Julie Totten, President and Founder of Families for Depression Awareness Julie Totten, M.B.A.

S15. Pros and Cons of SPECT Brain Imaging: What Is the Status of the Science?

1. Capturing Mental Illness in a Brain Scan: Dream or Reality? Anissa Abi-Dargham, M.D.

2. SPECT Imaging in Psychiatric Practice: Ready for Prime Time? Jair C. Soares, M.D.

3. Brain SPECT Imaging Is Immediately Useful in Clinical Practice Daniel G. Amen, M.D.

4. Bringing SPECT Functional Neuroimaging Into Perspective Theodore A. Henderson, M.D., Ph.D.

S16. Forensic Psychiatry: Informing Clinical Practice

1. Looking Beyond Patients’ Denial of Suicidal Ideation: Assessing Observable Evidence-Based Risk Factors Robert I. Simon, M.D.

2. Disability Evaluations: A Model for Assessment Liza H. Gold, M.D.

3. Neuroimaging in Forensic Psychiatry: Current Status and Future Directions Robert P. Granacher, M.D., M.B.A.

4. Correctional Psychiatry Joseph Penn, M.D.

5. The Internet and Psychiatry: An Update on Legal and Ethical Considerations Patricia R. Recupero, M.D., J.D.

6. Child Forensic Psychiatry: 21st Century Practice Cheryl D. Wills, M.D.

S17. STEPPS (Systems Training for Emotional Predictability and Problem Solving): Treating Borderline Personality Disorder in Diverse Settings Around the Globe

1. Overview of STEPPS Treatment Program and Its Implementation in Correctional Settings (Prisons and Community Corrections) Nancee S. Blum, M.S.W., L.C.S.W.

2. Implementing STEPPS in Different Service Settings in the United Kingdom Renee Harvey, M.A.

3. STEPPS in the Netherlands: The Efficacy in a Group of Dutch Patients With Borderline Personality Disorder and With Borderline Personality Features E. van Wel, M.D.

4. STEPPS Treatment of Inpatients With Mood Disorders and Co-occurring Borderline Personality Disorder Diagnosis: Preliminary Results From a One-Year Follow-Up Study Andrea Fossati, M.D., Ph.D.

S18. Narcissistic Personality Disorder inDSM-5:Impact on Research, Diagnosis, and Treatment

1. Narcissistic Personality Disorder in DSM-5Andrew E. Skodol, M.D.

2. Finding Common Denominators: Understanding the Association of Depression, Depressive Personality, and Hypersensitive (Vulnerable) Narcissism Steven Huprich, Ph.D.

3. Narcissistic Grandiosity and Narcissistic Vulnerability: Clinical Examples, Current Research, and Implications for DSM-5 Aaron L. Pincus, Ph.D.

4. Narcissistic Personality Disorder: An Interactive Exploratory Diagnostic Process Elsa Ronningstam, Ph.D.

5. Transference-Focused Psychotherapy for Narcissistic Personality Disorder Diana Diamond, Ph.D.

S19. Philosophical and Pragmatic Problems forDSM-5

1. The Ideology Behind DSM-5 Joel Paris, M.D.

2. The Conceptual Status of DSM Diagnoses James E. Phillips, M.D.

3. Considering the Economy of DSM Alternatives John Z. Sadler, M.D.

4. What Are the Benefits and Risks of Conservatism? G. Scott Waterman, M.D.

5. The Pragmatic Context of Psychiatric Diagnosis Joseph M. Pierre, M.D.

S20. New Paradigms for Investigating Relational Disturbances in Borderline Personality Disorder

1. Attachment and Cognition in BPD: Problems in Integrating Complex Information in Emotionally Stimulated Attachment Contexts Lois W. Choi-Kain, M.D., M.Ed.

2. Rejection Sensitivity as a Distinguishing Feature of Borderline Personality Disorder Valerie I. Photos, Ph.D.

3. Empathy, Attachment, and Borderline Personality: Genetic, Neurobio-logical, and Developmental Perspectives Luis H. Ripoll, M.D.

4. Emerging Investigational Paradigms for the Empirical Study of Rejection Sensitivity Alex S. Keuroghlian, M.D., M.Sc.

5. Neuroimaging of Social Exclusion in Borderline Personality Disorder Anthony C. Ruocco, Ph.D.

3:30 P.M.-5 P.M.

LECTURES

L6. Schizophrenia as a Learning and Memory DisorderAPA Distinguished Psychiatrist Lecture; Carol A. Tamminga, M.D.

L7. Musings on Decades of Progress in Alcoholism Treatment ResearchU.S. National Institute on Alcohol Abuse and Alcoholism;Bankole A. Johnson, M.D.

SCIENTIFIC AND CLINICAL REPORTS

SCR5. Bipolar Disorders, Part 2

1. Is Antidepressant Use in Bipolar Disorder Associated With Higher Readmission Rates? Megan Ehret, Pharm.D.

2. WITHDRAWN 3. Increased Life Events in Bipolar II Patients Participating in Bipolar Bio-bank Mohit Chauhan, M.B.B.S.

SCR6. Borderline Personality Disorder, Diagnostic Issues

1. Is Dimensional Scoring of Borderline Personality Disorder Only Important for Subthreshold Levels of Severity? Mark Zimmerman, M.D.

2. Distinguising Bipolar II and Borderline Personality Disorder: A Review of Current Literature Katy Crow

3. Borderline Personality Disorder and Atypical Depression: Controversies and Convergences Ana Marie Rodriguez-Villa

WORKSHOPS

W20. Understanding Genetics: It’s Not Just Mendelian AnymoreChair: Michele T. Pato, M.D.

W21. Children of PsychiatristsChairs: Michelle B. Riba, M.D., M.S., Leah J. Dickstein, M.D., M.A.

W22. Promoting Improved Integration: The Role of Collaborative Health Care in Today’s SocietyChair: Peter S. Martin, M.D., M.P.H.

W23. Responding to the Impact of Suicide on CliniciansChair: Eric M. Plakun, M.D.

W24. Making the Most of Your Chief Year: Chief Residents’ Forum IChairs: Margaret E. Haglund, M.D., Jason E. Cheng, M.D.

W25. Joining the Ranks of Military Psychiatry as a Civilian Contractor: Lessons LearnedChair: Elspeth C. Ritchie, M.D., M.P.H.